Ivermectin shows clinical benefits in mild to moderate COVID19: RCT double-blind
1–10 of 61 posts
Re: Ivermectin shows clinical benefits in mild to moderate COVID19: RCT double-blind
#2b) "Sixty-three patients with positive PCR result were randomized into three arms of the study. There was 1 withdrawal, thus 62 patients completed the study" [0]
c) "We cannot conclude in this study that Ivermectin has a place in prophylaxis, but this warrants investigation." [0]
[0] https://academic.oup.com/qjmed/advance-article/doi/10.1093/q...
Re: Ivermectin shows clinical benefits in mild to moderate COVID19: RCT double-blind
#3Re: Ivermectin shows clinical benefits in mild to moderate COVID19: RCT double-blind
#4Re: Ivermectin shows clinical benefits in mild to moderate COVID19: RCT double-blind
#5Re: Ivermectin shows clinical benefits in mild to moderate COVID19: RCT double-blind
#6That said, I was wrong, removed. I guess it's too much to ask for people to trust the recommended medicine, perhaps we should get more pro-vaccine conspiracy theories out there =/
Re: Ivermectin shows clinical benefits in mild to moderate COVID19: RCT double-blind
#7Re: Ivermectin shows clinical benefits in mild to moderate COVID19: RCT double-blind
#8The whole Ivermectin controversy has been so strange given that it's known to be safe. If it's effective great and if not then there's no harm.
And pfizer and pharma companies lose billions and billions of dollars.
Hence why it has been so strange...
Re: Ivermectin shows clinical benefits in mild to moderate COVID19: RCT double-blind
#9Trial group of 62 patients and no parasite screening in those patients - yawn. But could be interesting grounds for a more significant and controlled study with patients with comorbidities.
Re: Ivermectin shows clinical benefits in mild to moderate COVID19: RCT double-blind
#10Trial group of 62 patients and no parasite screening in those patients - yawn. But could be interesting grounds for a more significant and controlled study with patients with comorbidities.
Here's Cochran's meta-study; Cochran is, from what I can tell, very well-regarded. It appears to include this study. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD...
Later
For what it's worth: the boy rebuts this with the observation that you'd expect worsening symptoms for patients with actual parasitic infection, since there's an immune response to necrotic parasite tissue when ivermectin works. None of us here are ivermexperts though!